Open AccessS213: EFFICACY AND SAFETY OF HUMANIZED VERSUS MURINIZED CD19 AND CD22 CAR‐T CELL COCKTAIL THERAPY FOR REFRACTORY/RELAPSED B‐CELL LYMPHOMA
Author(s) -
Huang L.,
Li J.,
Yang J.,
Zhang X.,
Zhang M.,
He J.,
Zhang G.,
Su Y.,
Li W.,
Wang H.,
Lu P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843744.47241.17
Subject(s) - medicine , fludarabine , cytokine release syndrome , follicular lymphoma , lymphoma , cyclophosphamide , cd19 , b cell , oncology , refractory (planetary science) , immunology , chimeric antigen receptor , gastroenterology , antigen , chemotherapy , immunotherapy , cancer , biology , antibody , astrobiology